Literature DB >> 15468994

Role of skin-lined tracheotomy in obstructive sleep apnoea syndrome: personal experience.

A Campanini1, A De Vito, S Frassineti, C Vicini.   

Abstract

Permanent tracheotomy was the first surgical procedure proposed for the treatment of severe obstructive sleep apnoea syndrome and is still the only surgical option that ensures, even in very severe cases, complete elimination of apnoea and, in turn, clinical remission. Improved knowledge of the causes of obstructive sleep apnoea syndromes and the increasing therapeutic options (instrumental, medical and surgical) have resulted in cases requiring tracheotomy as the only indispensable therapeutic option becoming more rare. At present, the only indications are in very occasional conditions of life-threatening obstructive sleep apnoea syndromes and in patients on whom continuous positive airway pressure is not tolerated or is not effective (severe deoxygenation or hypercapnia, severe respiratory disorder index, severe obstructive sleep apnoea syndrome-related arrhythmias, severe excessive daytime sleepiness, heart diseases or ischaemic encephalopathy exacerbated by obstructive sleep apnoea syndromes, obstructive pneumopathy exacerbated by obstructive sleep apnoea syndromes, severe obstructive sleep apnoea syndromes with few chances of resolution with other surgical procedures or failure of the latter). Moreover, it is the only therapeutic solution in rare nocturnal laryngeal stridor due to multisystemic atrophy (in which obstructive sleep apnoea syndrome is due to nocturnal laryngospasm of neurologic origin). Therapeutic tracheotomy must be permanent (tracheostomy) and, therefore, preferably carried out with a specific technique (skin-lined tracheotomy), able to guarantee greater stability, less risk of granulation tissue, wider opening of the tracheostomy, sufficient reversibility. In our experience, very few patients (10 cases) withsleep disorder breathing have been submitted to skin-lined tracheotomy. Of these, the majority were submitted to surgery for severe apnoea due to nocturnal laryngospasm on account of multisystemic atrophy (n = 7), while only 3 cases of obstructive sleep apnoea syndromes were submitted to skin-lined tracheotomy, i.e., 0.7% of the 424 patients operated on for obstructive sleep apnoea syndrome and 1.7% of the 175 operated on for severe, or very severe, obstructive sleep apnoea syndromes (RDI > 40). Skin-lined tracheotomy was not followed by important complications and expected results were achieved with immediate disappearance of daytime symptoms and considerable improvement in nocturnal apnoea. Besides sleep-related disorders, numerous clinical situations with indications for a permanent tracheotomy may benefit from the skinlined technique, such as severe laryngeal or tracheal stenoses, laryngeal diplegias, miasthenia gravis, lateral amyotrophic sclerosis, intractable aspiration, severe emphysema.

Entities:  

Mesh:

Year:  2004        PMID: 15468994

Source DB:  PubMed          Journal:  Acta Otorhinolaryngol Ital        ISSN: 0392-100X            Impact factor:   2.124


  4 in total

1.  On the way to total integration of prosthetic pylon with residuum.

Authors:  Mark Pitkin
Journal:  J Rehabil Res Dev       Date:  2009

2.  Stridor in multiple system atrophy: Consensus statement on diagnosis, prognosis, and treatment.

Authors:  Pietro Cortelli; Giovanna Calandra-Buonaura; Eduardo E Benarroch; Giulia Giannini; Alex Iranzo; Phillip A Low; Paolo Martinelli; Federica Provini; Niall Quinn; Eduardo Tolosa; Gregor K Wenning; Giovanni Abbruzzese; Pamela Bower; Enrico Alfonsi; Imad Ghorayeb; Tetsutaro Ozawa; Claudio Pacchetti; Nicolò Gabriele Pozzi; Claudio Vicini; Angelo Antonini; Kailash P Bhatia; Jacopo Bonavita; Horacio Kaufmann; Maria Teresa Pellecchia; Nicole Pizzorni; Antonio Schindler; François Tison; Luca Vignatelli; Wassilios G Meissner
Journal:  Neurology       Date:  2019-10-01       Impact factor: 9.910

3.  Tracheostomy is associated with increased survival in Multiple System Atrophy patients with stridor.

Authors:  Giulia Giannini; Federica Provini; Ilaria Cani; Annagrazia Cecere; Francesco Mignani; Pietro Guaraldi; Cristian Vincenzo Francesco Di Mirto; Pietro Cortelli; Giovanna Calandra-Buonaura
Journal:  Eur J Neurol       Date:  2022-04-15       Impact factor: 6.288

Review 4.  OSAS and metabolic diseases: Round Table, 99(th) SIO National Congress, Bari 2012.

Authors:  D Passàli; P Tatti; M Toraldo; M de Benedetto; F Peverini; G Caruso; A Marzetti; F M Passàli; L Bellussi
Journal:  Acta Otorhinolaryngol Ital       Date:  2014-06       Impact factor: 2.124

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.